Skip to main content
logo
TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
2.220
0.00 (0.00%)
At close: Aug 28, 2026, 4:00 PM EDT
2.200
-0.020 (-0.90%)
After-hours: Aug 28, 2026, 6:54 PM EDT

TherapeuticsMD Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-0.22-0.57-2.18-10.28112-172.42
Depreciation & Amortization
1.291.191.280.441.190.74
Asset Writedown & Restructuring Costs
0.10.181.270.48--
Stock-Based Compensation
0.060.080.261.2711.5718.13
Other Operating Activities
-0.08-0.08-0.132.45-111.3293.83
Change in Accounts Payable
0.110.120.23-2.14-1.21-1.06
Change in Other Net Operating Assets
1.841.540.44-15.31-2.885.65
Operating Cash Flow
3.122.420.73-48.14-4.08-142.69
Operating Cash Flow Growth
272.76%231.15%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
------0.03
Sale (Purchase) of Intangibles
-----0.36-2.19
Other Investing Activities
----223.83-
Investing Cash Flow
----223.48-2.22

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
-----219.43-50
Net Debt Issued (Repaid)
-----219.43-50
Issuance of Common Stock
---3.152.47184.67
Other Financing Activities
-----1.27-5.12
Financing Cash Flow
---3.15-235.21129.55

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
3.122.420.73-44.99-15.81-15.36

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
3.122.420.73-48.14-4.08-142.73
Free Cash Flow Growth
272.76%231.15%----
Free Cash Flow Margin
95.41%80.21%41.57%-3697.46%-5.83%-5547.10%
Free Cash Flow Per Share
0.270.210.06-4.61-0.43-17.93
Levered Free Cash Flow
0.90.3-2.22-33.8738.54-28.46
Unlevered Free Cash Flow
0.90.3-2.22-33.8738.54-28.46

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
----13.5525.07
Change in Working Capital
1.951.660.67-17.45-4.094.59
SEC Filings: 10-K · 10-Q